发明名称 GLYCOALKALOIDS
摘要 2073855 9110743 PCTABS00006 The invention is directed to the control of cellular autophagy, cellular agglutination and the immobilization of motile cells. Such control is useful in, for example, the treatment of cancer, contraception, termination of pregnancy, removal of pathogenic organisms and removal of any abnormal cellular growth (malignant or otherwise); as a diagnostic and analytical tool whereby cell structure can be studied and testing could be undertaken for the presence (and subsequent analysis) of pathogenic and non-pathogenic organisms; and in the manufacture of biochemicals whereby certain cells must be destroyed or otherwise contained. From surface analysis of normal and abnormal cells, specific receptors on abnormal cells which are either not present on normal cells or are only present insignificantly reduced numbers can be identified. Alkaloids and other pharmaceutically acceptable compounds are preferentially recognised by the abnormal cells, and which bind thereto and subsequently destroy.
申请公布号 CA2073855(A1) 申请公布日期 1991.07.19
申请号 CA19912073855 申请日期 1991.01.18
申请人 CURA NOMINEES PTY LTD. 发明人 CHAM, BILL E.;DAUNTER, BRIAN
分类号 A61K31/58;A61K31/20;A61K31/565;A61K31/57;A61K31/575;A61K31/704;A61K36/81;A61K38/27;A61K49/00;A61K51/00;A61P35/00;C07J1/00;C07J7/00;C07J9/00;C07J17/00;C07J21/00;C07J43/00;C07J71/00;C12Q1/02;C12Q1/04;C12Q1/18;G01N33/50;G01N33/53;G01N33/532;G01N33/569;G01N33/574;G01N33/74;(IPC1-7):C12Q1/02;C07J73/00;A61K49/02;A61K38/19;A61K38/28;A61K31/705 主分类号 A61K31/58
代理机构 代理人
主权项
地址